Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.

Ferrua F, Cicalese MP, Galimberti S, Giannelli S, Dionisio F, Barzaghi F, Migliavacca M, Bernardo ME, Calbi V, Assanelli AA, Facchini M, Fossati C, Albertazzi E, Scaramuzza S, Brigida I, Scala S, Basso-Ricci L, Pajno R, Casiraghi M, Canarutto D, Salerio FA, Albert MH, Bartoli A, Wolf HM, Fiori R, Silvani P, Gattillo S, Villa A, Biasco L, Dott C, Culme-Seymour EJ, van Rossem K, Atkinson G, Valsecchi MG, Roncarolo MG, Ciceri F, Naldini L, Aiuti A.

Lancet Haematol. 2019 Apr 10. pii: S2352-3026(19)30021-3. doi: 10.1016/S2352-3026(19)30021-3. [Epub ahead of print]

2.

Lentiviral gene therapy corrects platelet phenotype and function in Wiskott-Aldrich patients.

Sereni L, Castiello MC, Di Silvestre D, Della Valle P, Brombin C, Ferrua F, Cicalese MP, Pozzi L, Migliavacca M, Bernardo ME, Pignata C, Farah R, Notarangelo LD, Marcus N, Cattaneo L, Spinelli M, Giannelli S, Bosticardo M, van Rossem K, D'Angelo A, Aiuti A, Mauri P, Villa A.

J Allergy Clin Immunol. 2019 Mar 26. pii: S0091-6749(19)30410-5. doi: 10.1016/j.jaci.2019.03.012. [Epub ahead of print]

3.
4.

Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial.

Vahlquist A, Blockhuys S, Steijlen P, van Rossem K, Didona B, Blanco D, Traupe H.

Br J Dermatol. 2014 Jan;170(1):173-81. doi: 10.1111/bjd.12626.

5.

A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis.

Sigurgeirsson B, van Rossem K, Malahias S, Raterink K.

J Am Acad Dermatol. 2013 Sep;69(3):416-25. doi: 10.1016/j.jaad.2013.03.021. Epub 2013 May 22.

PMID:
23706639
8.

In vitro profiling of pramiconazole and in vivo evaluation in Microsporum canis dermatitis and Candida albicans vaginitis laboratory models.

de Wit K, Paulussen C, Matheeussen A, van Rossem K, Cos P, Maes L.

Antimicrob Agents Chemother. 2010 Nov;54(11):4927-9. doi: 10.1128/AAC.00730-10. Epub 2010 Aug 30.

9.

Application of NIRS in mice: a study comparing the oxygenation of cerebral blood and main tissue oxygenation of mice and rat.

De Visscher G, Verreth W, Blockx H, van Rossem K, Holvoet P, Flameng W.

Adv Exp Med Biol. 2006;578:197-202. No abstract available.

PMID:
16927693
10.

Pentobarbital fails to reduce cerebral oxygen consumption early after non-hemorrhagic closed head injury in rats.

De Visscher G, Rooker S, Jorens P, Verlooy J, Borgers M, Reneman RS, Van Rossem K, Flameng W.

J Neurotrauma. 2005 Jul;22(7):793-806.

PMID:
16004582
11.

Identifying modulators of hERG channel activity using the PatchXpress planar patch clamp.

Dubin AE, Nasser N, Rohrbacher J, Hermans AN, Marrannes R, Grantham C, Van Rossem K, Cik M, Chaplan SR, Gallacher D, Xu J, Guia A, Byrne NG, Mathes C.

J Biomol Screen. 2005 Mar;10(2):168-81.

PMID:
15799960
12.

Norpiperidine imidazoazepines as a new class of potent, selective, and nonsedative H1 antihistamines.

Janssens F, Leenaerts J, Diels G, De Boeck B, Megens A, Langlois X, van Rossem K, Beetens J, Borgers M.

J Med Chem. 2005 Mar 24;48(6):2154-66.

PMID:
15771458
13.

Nirs mediated CBF assessment: validating the indocyanine green bolus transit detection by comparison with coloured microsphere flowmetry.

De Visscher G, Leunens V, Borgers M, Reneman RS, Flameng W, van Rossem K.

Adv Exp Med Biol. 2003;540:37-45. No abstract available.

PMID:
15174600
14.

Detection of proarrhythmia in the female rabbit heart: blinded validation.

Hondeghem LM, Lu HR, van Rossem K, De Clerck F.

J Cardiovasc Electrophysiol. 2003 Mar;14(3):287-94.

PMID:
12716112
15.

[Who would suffer this child in the cold? History and diagnosis during a Socratic dialogue].

Van Rossem K, Bolten H.

Rev Belge Med Dent (1984). 2002;57(4):278-91. French.

PMID:
12649970
16.

[The extraction of truth: apropos of the Socratic dialogue].

Van Rossem K, Bolten H.

Rev Belge Med Dent (1984). 2002;57(4):257-77. French.

PMID:
12649969
17.

Development of a novel fluorescent microsphere technique to combine serial cerebral blood flow measurements with histology in the rat.

De Visscher G, Haseldonckx M, Flameng W, Borgers M, Reneman RS, van Rossem K.

J Neurosci Methods. 2003 Jan 30;122(2):149-56.

PMID:
12573474
18.

Comparison of intracranial pressure measured in the cerebral cortex and the cerebellum of the rat.

Rooker S, De Visscher G, Van Deuren B, Borgers M, Jorens PG, Reneman RS, van Rossem K, Verlooy J.

J Neurosci Methods. 2002 Sep 15;119(1):83-8.

PMID:
12234639
19.

Cerebral blood flow assessment with indocyanine green bolus transit detection by near-infrared spectroscopy in the rat.

De Visscher G, van Rossem K, Van Reempts J, Borgers M, Flameng W, Reneman RS.

Comp Biochem Physiol A Mol Integr Physiol. 2002 May;132(1):87-95.

PMID:
12062195
20.

In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity.

De Clerck F, Van de Water A, D'Aubioul J, Lu HR, van Rossem K, Hermans A, Van Ammel K.

Fundam Clin Pharmacol. 2002 Apr;16(2):125-40. Review.

PMID:
12031065

Supplemental Content

Loading ...
Support Center